Filing Details

Accession Number:
0000930413-11-007438
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-11-17 11:49:30
Reporting Period:
2011-11-16
Filing Date:
2011-11-17
Accepted Time:
2011-11-17 11:49:30
Original Submission Date:
2011-11-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901503 W Barry Weiner C/O Enzo Biochem, Inc.
527 Madison Avenue
New York, NY 10022
Pres, Cfo, Princ Ao And Treasr Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 2,000 $2.25 1,294,206 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 2,182 $2.27 1,296,388 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 6,000 $2.28 1,302,388 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 3,000 $2.29 1,305,388 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 4,818 $2.30 1,310,206 No 4 P Direct
Common Stock, Par Value $0.01 Per Share Acquisiton 2011-11-16 2,000 $2.32 1,312,206 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. This amendment is being filed solely to correct a typographical error in box 4 of Table I to correctly indicate that the securities were acquired and not disposed of.
  2. Includes (i) 239,000 shares of Common Stock issuable upon the exercise of options which are exercisable within 60 days from the date hereof, (ii) 3,638 shares of Common Stock held in the name of the Reporting Person as custodian for certain of his children and (iii) 12,510 shares of Common Stock held in the Company's 401(k) plan.